BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32780864)

  • 1. CNTF Prevents Development of Outer Retinal Neovascularization Through Upregulation of CxCl10.
    Bucher F; Aguilar E; Marra KV; Rapp J; Arnold J; Diaz-Aguilar S; Lange C; Agostini H; Schlunck G; Stahl A; Friedlander M
    Invest Ophthalmol Vis Sci; 2020 Aug; 61(10):20. PubMed ID: 32780864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CNTF Attenuates Vasoproliferative Changes Through Upregulation of SOCS3 in a Mouse-Model of Oxygen-Induced Retinopathy.
    Bucher F; Walz JM; Bühler A; Aguilar E; Lange C; Diaz-Aguilar S; Martin G; Schlunck G; Agostini H; Friedlander M; Stahl A
    Invest Ophthalmol Vis Sci; 2016 Aug; 57(10):4017-26. PubMed ID: 27494343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
    Kim KL; Suh W
    Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of brimonidine on retinal and choroidal neovascularization in a mouse model of retinopathy of prematurity and laser-treated rats.
    Kusari J; Padillo E; Zhou SX; Bai Y; Wang J; Song Z; Zhu M; Le YZ; Gil DW
    Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5424-31. PubMed ID: 21482645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Urokinase Receptor-Derived Peptide UPARANT Mitigates Angiogenesis in a Mouse Model of Laser-Induced Choroidal Neovascularization.
    Cammalleri M; Dal Monte M; Locri F; Lista L; Aronsson M; Kvanta A; Rusciano D; De Rosa M; Pavone V; André H; Bagnoli P
    Invest Ophthalmol Vis Sci; 2016 May; 57(6):2600–2611. PubMed ID: 27168367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol inhibits pathologic retinal neovascularization in Vldlr(-/-) mice.
    Hua J; Guerin KI; Chen J; Michán S; Stahl A; Krah NM; Seaward MR; Dennison RJ; Juan AM; Hatton CJ; Sapieha P; Sinclair DA; Smith LE
    Invest Ophthalmol Vis Sci; 2011 Apr; 52(5):2809-16. PubMed ID: 21282584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraperitoneal administration of adipose tissue-derived stem cells for the rescue of retinal degeneration in a mouse model via indigenous CNTF up-regulation by IL-6.
    Heo JH; Yoon JA; Ahn EK; Kim H; Urm SH; Oak CO; Yu BC; Lee SJ
    J Tissue Eng Regen Med; 2018 Mar; 12(3):e1370-e1382. PubMed ID: 28715614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinal Inhibition of CCR3 Induces Retinal Cell Death in a Murine Model of Choroidal Neovascularization.
    Wang H; Han X; Gambhir D; Becker S; Kunz E; Liu AJ; Hartnett ME
    PLoS One; 2016; 11(6):e0157748. PubMed ID: 27309355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Both Autocrine Signaling and Paracrine Signaling of HB-EGF Enhance Ocular Neovascularization.
    Inoue Y; Shimazawa M; Nakamura S; Takata S; Hashimoto Y; Izawa H; Masuda T; Tsuruma K; Sakaue T; Nakayama H; Higashiyama S; Hara H
    Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):174-185. PubMed ID: 29191924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiangiogenic effect of dasatinib in murine models of oxygen-induced retinopathy and laser-induced choroidal neovascularization.
    Seo S; Suh W
    Mol Vis; 2017; 23():823-831. PubMed ID: 29225458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of laser-induced choroidal neovascularization by a CCR3 antagonist.
    Mizutani T; Ashikari M; Tokoro M; Nozaki M; Ogura Y
    Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):1564-72. PubMed ID: 23404125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocan Blockade Suppresses Experimental Ocular Neovascularization in Mice.
    Su T; Zhong Y; Demetriades AM; Shen J; Sui A; Yao Y; Gao Y; Zhu Y; Shen X; Xie B
    Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):930-939. PubMed ID: 29450540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laser-induced choroidal neovascularization in mice attenuated by deficiency in the apelin-APJ system.
    Hara C; Kasai A; Gomi F; Satooka T; Sakimoto S; Nakai K; Yoshioka Y; Yamamuro A; Maeda S; Nishida K
    Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4321-9. PubMed ID: 23722395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic rapamycin inhibits retinal and choroidal neovascularization in mice.
    Dejneka NS; Kuroki AM; Fosnot J; Tang W; Tolentino MJ; Bennett J
    Mol Vis; 2004 Dec; 10():964-72. PubMed ID: 15623986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sema3f Protects Against Subretinal Neovascularization In Vivo.
    Sun Y; Liegl R; Gong Y; Bühler A; Cakir B; Meng SS; Burnim SB; Liu CH; Reuer T; Zhang P; Walz JM; Ludwig F; Lange C; Agostini H; Böhringer D; Schlunck G; Smith LEH; Stahl A
    EBioMedicine; 2017 Apr; 18():281-287. PubMed ID: 28373097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CNTF-mediated protection of photoreceptors requires initial activation of the cytokine receptor gp130 in Müller glial cells.
    Rhee KD; Nusinowitz S; Chao K; Yu F; Bok D; Yang XJ
    Proc Natl Acad Sci U S A; 2013 Nov; 110(47):E4520-9. PubMed ID: 24191003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of ocular angiogenesis by Notch signaling: implications in neovascular age-related macular degeneration.
    Ahmad I; Balasubramanian S; Del Debbio CB; Parameswaran S; Katz AR; Toris C; Fariss RN
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):2868-78. PubMed ID: 21228388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of PGE2 receptor EP4 in pathologic ocular angiogenesis.
    Yanni SE; Barnett JM; Clark ML; Penn JS
    Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5479-86. PubMed ID: 19494202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockout of αA-crystallin inhibits ocular neovascularization.
    Xu Q; Bai Y; Huang L; Zhou P; Yu W; Zhao M
    Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):816-26. PubMed ID: 25574047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical nepafenac inhibits ocular neovascularization.
    Takahashi K; Saishin Y; Saishin Y; Mori K; Ando A; Yamamoto S; Oshima Y; Nambu H; Melia MB; Bingaman DP; Campochiaro PA
    Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):409-15. PubMed ID: 12506103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.